Phthalocyanine

DB12983InvestigationalSmall molecule

Phthalocyanine is under investigation in clinical trial NCT00103246 (Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II...

Chemical structure of Phthalocyanine
Formula / weight
C32H18N8 · 514.552 g/mol (avg)
Also known as
Pigment blue 16

Resolves to

Compound
UNIIV5PUF4VLGYCAS574-93-6ChEMBLCHEMBL262101ChEBI34921PubChem5282330KEGGC14077
Clinical / RWD
RxNorm1999764
Structure
InChIKeyIEQIEDJGQAUEQZ-UHFFFAOYSA-NSMILESN1C2=C3C=CC=CC3=C1\N=C1/N=C(/N=C3\N=C(NC4=N\C(=N/2)C2=CC=CC=C42)C2=CC=CC=C32)C2=CC=CC=C12
Targets
P05067APP

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Phthalocyanine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In